Search results
Oct 19, 2022 · Oct 19, 2022, 09:08 ET. Share this article. BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), the leading horizontal platform for cell programming,...
Jan 10, 2022 · SAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is...
Oct 19, 2022 · Oct. 19, 2022, 09:08 AM. BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen...
Jan 10, 2022 · SAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is...
Apr 22, 2021 · Zymergen’s first product is a transparent polymer film, called Hyaline, that it’s marketing for use in consumer electronics. It has 10 other products in development in electronics, personal...
Jul 25, 2022 · (RTTNews) - Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which...
Oct 10, 2020 · With $300 Million In New Funding, Zymergen Aims To Sustainably Transform The $3 Trillion Chemical And Materials Industry. John Cumbers. Senior Contributor. Synthetic biology author. Follow. Click...